127 related articles for article (PubMed ID: 24356412)
21. Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience.
Gallotta V; Conte C; Giudice MT; Nero C; Vizzielli G; Gueli Alletti S; Cianci S; Lodoli C; Di Giorgio A; De Rose AM; Fagotti A; Scambia G; Ferrandina G
J Minim Invasive Gynecol; 2018; 25(4):644-650. PubMed ID: 29081384
[TBL] [Abstract][Full Text] [Related]
22. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
[TBL] [Abstract][Full Text] [Related]
23. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
[TBL] [Abstract][Full Text] [Related]
24. Surgical resection of recurrent endometrial carcinoma.
Awtrey CS; Cadungog MG; Leitao MM; Alektiar KM; Aghajanian C; Hummer AJ; Barakat RR; Chi DS
Gynecol Oncol; 2006 Sep; 102(3):480-8. PubMed ID: 16490236
[TBL] [Abstract][Full Text] [Related]
25. Surgery in recurrent epithelial ovarian cancer: benefits on Survival for patients with residual disease of 0.1-1 cm after secondary cytoreduction.
Tian WJ; Jiang R; Cheng X; Tang J; Xing Y; Zang RY
J Surg Oncol; 2010 Mar; 101(3):244-50. PubMed ID: 20112269
[TBL] [Abstract][Full Text] [Related]
26. Tertiary cytoreduction in patients with recurrent ovarian carcinoma.
Leitao MM; Kardos S; Barakat RR; Chi DS
Gynecol Oncol; 2004 Oct; 95(1):181-8. PubMed ID: 15385129
[TBL] [Abstract][Full Text] [Related]
27. Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Shibata K; Nagasaka T; Kikkawa F
Int J Gynecol Cancer; 2019 Jun; 29(5):910-915. PubMed ID: 30839284
[TBL] [Abstract][Full Text] [Related]
28. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer.
Kolev V; Mironov S; Mironov O; Ishill N; Moskowitz CS; Gardner GJ; Levine DA; Hricak H; Barakat RR; Chi DS
Int J Gynecol Cancer; 2010 Aug; 20(6):979-84. PubMed ID: 20683405
[TBL] [Abstract][Full Text] [Related]
30. Survival after repeat hepatic resection for recurrent colorectal metastases.
Chiappa A; Zbar AP; Biella F; Staudacher C
Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
[TBL] [Abstract][Full Text] [Related]
31. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
[TBL] [Abstract][Full Text] [Related]
32. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
[TBL] [Abstract][Full Text] [Related]
33. Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.
Shih KK; Chi DS; Barakat RR; Leitao MM
Gynecol Oncol; 2010 May; 117(2):330-5. PubMed ID: 20189234
[TBL] [Abstract][Full Text] [Related]
34. Recurrent micropapillary serous ovarian carcinoma.
Bristow RE; Gossett DR; Shook DR; Zahurak ML; Tomacruz RS; Armstrong DK; Montz FJ
Cancer; 2002 Aug; 95(4):791-800. PubMed ID: 12209723
[TBL] [Abstract][Full Text] [Related]
35. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
[TBL] [Abstract][Full Text] [Related]
36. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer.
Gadducci A; Iacconi P; Cosio S; Fanucchi A; Cristofani R; Riccardo Genazzani A
Gynecol Oncol; 2000 Dec; 79(3):344-9. PubMed ID: 11104603
[TBL] [Abstract][Full Text] [Related]
37. Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Shih KK; Chi DS; Barakat RR; Leitao MM
Gynecol Oncol; 2010 Mar; 116(3):364-9. PubMed ID: 19897231
[TBL] [Abstract][Full Text] [Related]
38. [Significance of hepatic resection in the treatment of hepatic parenchymal metastasis of recurrent epithelial ovarian carcinoma].
Yan X; Bao Q; An N; Gao YN; Jiang GQ; Gao M; Zheng H; Wang W
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):132-7. PubMed ID: 21575484
[TBL] [Abstract][Full Text] [Related]
39. Hepatic resection for recurrent metastatic ovarian cancer.
Abood G; Bowen M; Potkul R; Aranha G; Shoup M
Am J Surg; 2008 Mar; 195(3):370-3; discussion 373. PubMed ID: 18207130
[TBL] [Abstract][Full Text] [Related]
40. [Secondary cytoreductions in the treatment of ovarian cancers].
Zylberberg B; Dormont D; Janklewicz S; Daraï E; Madelenat P; Antoine JM
Gynecol Obstet Fertil; 2000 Feb; 28(2):127-36. PubMed ID: 10758587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]